Barriers to treatment for mental disorders in six countries of the Americas: A regional report from the World Mental Health Surveys.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 04 2022
Historique:
received: 31 05 2021
revised: 10 02 2022
accepted: 13 02 2022
pubmed: 18 2 2022
medline: 21 4 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

Mental health treatment is scarce and little resources are invested in reducing the wide treatment gap that exists in the Americas. The regional barriers are unknown. We describe the barriers for not seeking treatment among those with mental and substance use disorders from six (four low- and middle-income and two high-income) countries from the Americas. Regional socio-demographic and clinical correlates are assessed. Respondents (n = 4648) from seven World Mental Health surveys carried out in Argentina, Brazil, Colombia, Mexico, Peru, and the United States, who met diagnostic criteria for a 12-month mental disorder, measured with the Composite International Diagnostic Interview, and who did not access treatment, were asked about treatment need and, among those with need, structural and attitudinal barriers. Country-specific deviations from regional estimates were evaluated through logistic models. In the Americas, 43% of those that did not access treatment did not perceive treatment need, while the rest reported structural and attitudinal barriers. Overall, 27% reported structural barriers, and 95% attitudinal barriers. The most frequent attitudinal barrier was to want to handle it on their own (69.4%). Being female and having higher severity of disorders were significant correlates of greater perceived structural and lower attitudinal barriers, with few country-specific variations. Only six countries in the Americas are represented; the cross-sectional nature of the survey precludes any causal interpretation. Awareness of disorder or treatment need in various forms is one of the main barriers reported in the Americas and it specially affects persons with severe disorders.

Sections du résumé

BACKGROUND
Mental health treatment is scarce and little resources are invested in reducing the wide treatment gap that exists in the Americas. The regional barriers are unknown. We describe the barriers for not seeking treatment among those with mental and substance use disorders from six (four low- and middle-income and two high-income) countries from the Americas. Regional socio-demographic and clinical correlates are assessed.
METHODS
Respondents (n = 4648) from seven World Mental Health surveys carried out in Argentina, Brazil, Colombia, Mexico, Peru, and the United States, who met diagnostic criteria for a 12-month mental disorder, measured with the Composite International Diagnostic Interview, and who did not access treatment, were asked about treatment need and, among those with need, structural and attitudinal barriers. Country-specific deviations from regional estimates were evaluated through logistic models.
RESULTS
In the Americas, 43% of those that did not access treatment did not perceive treatment need, while the rest reported structural and attitudinal barriers. Overall, 27% reported structural barriers, and 95% attitudinal barriers. The most frequent attitudinal barrier was to want to handle it on their own (69.4%). Being female and having higher severity of disorders were significant correlates of greater perceived structural and lower attitudinal barriers, with few country-specific variations.
LIMITATIONS
Only six countries in the Americas are represented; the cross-sectional nature of the survey precludes any causal interpretation.
CONCLUSIONS
Awareness of disorder or treatment need in various forms is one of the main barriers reported in the Americas and it specially affects persons with severe disorders.

Identifiants

pubmed: 35176342
pii: S0165-0327(22)00180-X
doi: 10.1016/j.jad.2022.02.031
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-285

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Ricardo Orozco (R)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Electronic address: ric_oz@imp.edu.mx.

Daniel Vigo (D)

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America.

Corina Benjet (C)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.

Guilherme Borges (G)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.

Sergio Aguilar-Gaxiola (S)

Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, United States of America.

Laura H Andrade (LH)

Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Alfredo Cia (A)

Anxiety Disorders Center, Buenos Aires, Argentina.

Irving Hwang (I)

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America.

Marina Piazza (M)

Departamento Académico de Salud Pública, Administración y Ciencias Sociales, Universidad Peruana Cayetano Heredia, Lima, Peru.

José Posada-Villa (J)

Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogotá, Colombia.

Claudia Rafful (C)

Faculty of Psychology, UNAM, Center for Global Mental Health Research, National Institute of Psychiatry.

Nancy Sampson (N)

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America.

Juan Carlos Stagnaro (JC)

Departamento de Psiquiatría y Salud Mental, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Yolanda Torres (Y)

Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia.

María Carmen Viana (MC)

Department of Social Medicine and Post-Graduate Program in Public Health, Psychiatric Epidemiology Research Center (CEPEP), Federal University of Espírito Santo (UFES), Vitória, Brazil.

María-Elena Medina-Mora (ME)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH